Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 7, 2009; 15(29): 3636-3642
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3636
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3636
Table 2 Reason for dropout in both study groups n (%)
| Imipramine (n = 59) | Placebo (n = 48) | P-value | |
| Total dropouts | 28 (47.5) | 23 (47.9) | NS |
| Premature withdrawal | 8 (13.6) | 14 (29.2) | < 0.05 |
| Lost to follow-up | 3 (5.1) | 3 (6.3) | NS |
| Protocol violation | 3 | 0 | NS |
| Side effects | 14 (23.7) | 6 (12.5) | 0.094 |
- Citation: Abdul-Baki H, El Hajj II, ElZahabi L, Azar C, Aoun E, Skoury A, Chaar H, Sharara AI. A randomized controlled trial of imipramine in patients with irritable bowel syndrome. World J Gastroenterol 2009; 15(29): 3636-3642
- URL: https://www.wjgnet.com/1007-9327/full/v15/i29/3636.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3636